• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[淋巴细胞粘附抑制试验在弥漫性毒性甲状腺肿患者中的意义]

[The significance of the lymphocyte adherence inhibition test in patients with diffuse toxic goiter].

作者信息

Podil'chak M D, Makar D A, Kun M D

出版信息

Lik Sprava. 1992 Jul(7):95-7.

PMID:1449002
Abstract

Patients with diffuse toxic goiter reveal an increased adhesive capacity of lymphocytes evidencing a reduction of lymphokine production by lymphocytes which would suppress adhesiveness. The degree of increase of adhesive properties of lymphocytes depended on the severity of the clinical picture of diffuse toxic goiter, being higher in those with a severe course. Results of the test of lymphocyte adhesion suppression reflect the state of cellular immunity, severity of the clinical course of diffuse toxic goiter and efficacy of treatment.

摘要

弥漫性毒性甲状腺肿患者淋巴细胞的黏附能力增强,这表明淋巴细胞产生的抑制黏附性的淋巴因子减少。淋巴细胞黏附特性的增加程度取决于弥漫性毒性甲状腺肿临床表现的严重程度,病程严重的患者该程度更高。淋巴细胞黏附抑制试验的结果反映了细胞免疫状态、弥漫性毒性甲状腺肿临床病程的严重程度及治疗效果。

相似文献

1
[The significance of the lymphocyte adherence inhibition test in patients with diffuse toxic goiter].[淋巴细胞粘附抑制试验在弥漫性毒性甲状腺肿患者中的意义]
Lik Sprava. 1992 Jul(7):95-7.
2
[The clinical importance of determining lymphocyte succinate dehydrogenase activity and the count of large granule-containing lymphocytes in the peripheral blood of patients with diffuse toxic goiter].
Klin Khir (1962). 1991(12):4-6.
3
[Cytochrome oxidase activity of peripheral blood leukocytes in patients with diffuse toxic goiter].
Vrach Delo. 1990 Jan(1):36-7.
4
[The determination of natural killer cells in the peripheral blood of patients with diffuse toxic goiter].
Vrach Delo. 1990 May(5):51-2.
5
[Characteristics of immunological reactivity of patients with diffuse toxic goiter in relation to the duration of the disease].弥漫性毒性甲状腺肿患者免疫反应性特征与病程的关系
Probl Endokrinol (Mosk). 1986 May-Jun;32(3):7-10.
6
[The enteral syndrome in the clinical course of diffuse toxic goiter].
Lik Sprava. 1999 Jul(5):92-4.
7
[Spontaneous rosette formation reaction as a prognostic test in diffuse toxic goiter before and after surgical treatment].
Vrach Delo. 1981 Jul(7):27-9.
8
[Diffuse toxic goiter associated with autoimmune thyroiditis].[与自身免疫性甲状腺炎相关的弥漫性毒性甲状腺肿]
Probl Endokrinol (Mosk). 1985 Jul-Aug;31(4):13-6.
9
[Indicators of the T- and B-systems of immunity in patients with diffuse toxic goiter].[弥漫性毒性甲状腺肿患者免疫T系统和B系统的指标]
Probl Endokrinol (Mosk). 1983 Jan-Feb;29(1):23-7.
10
[Criteria of the test of suppression of thyroid uptake of I131 by triiodothyronine].[三碘甲状腺原氨酸抑制甲状腺摄取 I131 的试验标准]
Probl Endokrinol (Mosk). 1975 Jul-Aug;21(4):13-7.